Clinical Characteristics and Survival of Patients with Hairy Cell Leukemia Treated at the National Cancer Institute in Peru from 1999 to 2018

被引：0
|
作者：
Pena, Estefania [1 ]
Vasquez, Jule [1 ]
机构：
[1] Inst Nacl Enfermedades Neoplas, Dept Med Oncol, Lima, Peru
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
HCL; hairy cell leukemia; cladribine; rituximab; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IBCL-057
引用
收藏
页码：S399 / S400
页数：2
相关论文
共 50 条
  • [41] Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)
    Slaoui, Meriem
    Zoure, Abdou Azaque
    Mouh, Fatima Zahra
    Bensouda, Youssef
    El Mzibri, Mohammed
    Bakri, Youssef
    Amrani, Mariam
    BMC CANCER, 2018, 18
  • [42] Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)
    Meriem Slaoui
    Abdou Azaque Zoure
    Fatima Zahra Mouh
    Youssef Bensouda
    Mohammed El Mzibri
    Youssef Bakri
    Mariam Amrani
    BMC Cancer, 18
  • [43] Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute Clinical article
    Cahill, Kevin S.
    Claus, Elizabeth B.
    JOURNAL OF NEUROSURGERY, 2011, 115 (02) : 259 - 267
  • [44] A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada clinical trials group study BR.21
    Florescu, Marie
    Hasan, Baktiar
    Seymour, Lesley
    Ding, Keyue
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 590 - 598
  • [45] Clinical outcome and prognostic factors for patients treated in a phase I study at the National University Cancer Institute, Singapore (NCIS)
    Chee, C. E.
    Soo, R.
    Goh, B-C
    Yong, W. P.
    Lee, S. C.
    Tan, D. S.
    Wong, A.
    Chng, W. J.
    Heong, V.
    Tai, B. C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Survival trends of patients treated at the National Cancer Center Hospital, Japan, from 1962 to 1994
    Sato, Y
    Arimoto, H
    Ishikawa, KB
    Yoshimura, K
    Kaneko, S
    Koshiji, M
    Takada, T
    Yamaguchi, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (05) : 181 - 186
  • [47] Small Cell Lung Cancer: Clinical Characteristics and Survival of a Spanish Cohort of 221 Patients
    Nunez, B.
    Gomez, R.
    Sanchez, J.
    De la Puente, B.
    Alfaro, C.
    Calvo, V.
    Nunez, L.
    Blanco, M.
    Curto, I.
    Soriano, M.
    Mendez, M.
    Morito, A.
    Franco, F.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S621 - S622
  • [48] IMPROVED SURVIVAL OF GLIOBLASTOMA PATIENTS TREATED AT ACADEMIC CANCER PROGRAMS: A HOSPITALBASED STUDY FROM THE NATIONAL CANCER DATABASE
    Zhu, Ping
    Du, Xianglin
    Zhu, Jay-Jiguang
    Esquenazi, Yoshua
    NEURO-ONCOLOGY, 2017, 19 : 108 - 108
  • [49] Prognostic factors in invasive squamous cell carcinoma of the penis:: Analysis of 196 patients treated at the Brazilian National Cancer Institute
    Ornellas, Antonio Augusto
    Braga Nobrega, Bernardo Lindenberg
    Kin Chin, Eduardo Wei
    Wisnescky, Aristoteles
    Barbosa da Silva, Paulo Cesar
    de Santos Schwindt, Aline Barros
    JOURNAL OF UROLOGY, 2008, 180 (04): : 1354 - 1359
  • [50] Gefitinib in pre-treated patients with non-small cell lung cancer (NSCLC): Experience at Milan National Cancer Institute
    Bidoli, Paolo
    Formisano, Barbara
    Cortinovis, Diego
    Fusi, Alberto
    Nova, Paola
    Dimarco, Rosanna
    Bajetta, Emilio
    ANNALS OF ONCOLOGY, 2005, 16 : 21 - 21
12345